Valuation: Neuland Laboratories Limited

Market Cap 236B 2.45B 2.14B 1.98B 1.82B 3.44B 3.51B 23.66B 9.3B 116B 9.22B 9.02B 399B P/E 2027 *
56.4x
P/E 2028 * 40.9x
Enterprise Value 239B 2.48B 2.17B 2B 1.85B 3.48B 3.56B 23.95B 9.42B 117B 9.33B 9.13B 403B EV / Sales 2027 *
10.4x
EV / Sales 2028 * 8.57x
Free-Float
62.24%
Yield 2027 *
0.07%
Yield 2028 * 0.1%
1 day-1.87%
1 week-5.60%
Current month-1.11%
1 month+8.37%
3 months+20.40%
6 months+30.94%
Current year+21.28%
1 week 18,041.55
Extreme 18041.55
19,539
1 month 17,032.7
Extreme 17032.7
20,072
Current year 11,500
Extreme 11500
20,072
1 year 11,500
Extreme 11500
20,072
3 years 3,100.05
Extreme 3100.05
20,072
5 years 965.85
Extreme 965.85
20,072
10 years 247.3
Extreme 247.3
20,072
Manager TitleAgeSince
Chief Executive Officer 46 01/04/2026
Director of Finance/CFO - 23/11/2022
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member - 01/08/2025
Director/Board Member 80 31/10/2022
Director/Board Member 82 12/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.87%-5.60%+27.09%+526.35% 2.45B
+0.85%-0.80%+54.84%+163.70% 1,051B
+1.23%-1.53%+55.26%+59.07% 609B
+0.04%+2.58%+32.96%+88.75% 450B
+0.78%-0.71%+30.04%+24.61% 330B
+1.41%+0.58%+33.92%+47.20% 284B
-0.27%-1.87%+22.13%+23.47% 263B
-1.76%+2.37%-22.19%-38.45% 223B
-1.42%+0.80%+22.81%+60.77% 198B
-1.48%+3.43%+23.42%+73.31% 167B
Average -0.29%-0.07%+28.03%+102.88% 357.75B
Weighted average by Cap. +0.21%+0.02%+37.74%+81.80%

Financials

2027 *2028 *
Net sales 23.09B 240M 210M 193M 178M 336M 343M 2.31B 909M 11.31B 900M 881M 38.93B 27.8B 289M 252M 233M 215M 404M 413M 2.78B 1.09B 13.61B 1.08B 1.06B 46.87B
Net income 4.21B 43.71M 38.2M 35.25M 32.49M 61.24M 62.6M 421M 166M 2.06B 164M 161M 7.1B 5.81B 60.29M 52.68M 48.62M 44.81M 84.46M 86.34M 581M 229M 2.84B 226M 221M 9.79B
Net Debt 2.94B 30.5M 26.66M 24.6M 22.67M 42.73M 43.68M 294M 116M 1.44B 115M 112M 4.95B 1.92B 19.94M 17.43M 16.08M 14.82M 27.94M 28.56M 192M 75.6M 940M 74.89M 73.24M 3.24B
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
17/07/26 ₹18,422.80 -1.87% 1,641
16/07/26 ₹18,773.60 -1.66% 943
15/07/26 ₹19,089.60 +0.48% 625
14/07/26 ₹18,997.85 -0.01% 514
13/07/26 ₹18,999.05 -2.65% 1,908
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
18,422.80INR
Average target price
21,222.00INR
Spread / Average Target
+15.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock